A man presenting with a skin rash and left leg weakness was diagnosed with sarcoid-like reaction due to treatment for chronic lymphocytic leukemia, and ultimately also amyotrophic lateral sclerosis when the motor symptoms progressed.
Diabetes and NET can adversely affect each other’s prognosis, but what impact do NET therapies have on diabetes and vice versa? And how should radiological and functional procedures be managed in patients with NET and diabetes?
Compared with the general population, childhood cancer survivors have a twofold increased risk for melanoma, with substantially worse survival for those who develop invasive melanoma.
There are minimal data concerning treatment-free remission after discontinuation of the novel TKI asciminib in people with chronic myeloid leukemia. These two cases provide proof of principle that sustained TFR is possible in selected patients.
The risk for malignancy in people with spondyloarthritis remains a controversial issue. What is the current evidence for the impact of the disease and its treatment with biologic and targeted synthetic DMARDs?
POSITIVEly reassuring results from a clinical trial
The POSITIVE trial previously showed that women with breast cancer can safely interrupt endocrine therapy in order to become pregnant. But what about breastfeeding - is that possible and safe for the mother and baby?
Women can take heart from the latest findings, says Dr. Cristina Saura, as she takes us through these important clinical updates.
In this webinar, Professor Martin Dreyling and an esteemed international panel of CAR T-cell therapy experts discuss the latest data on the safety, efficacy, and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL.
Please note, this webinar is not intended for healthcare professionals based in the US and UK.
A man presenting with a skin rash and left leg weakness was diagnosed with sarcoid-like reaction due to treatment for chronic lymphocytic leukemia, and ultimately also amyotrophic lateral sclerosis when the motor symptoms progressed.
There are minimal data concerning treatment-free remission after discontinuation of the novel TKI asciminib in people with chronic myeloid leukemia. These two cases provide proof of principle that sustained TFR is possible in selected patients.
PVRL is a life-threatening neoplasm. It can be mistaken for non-infectious uveitis, as it often presents with vitritis that responds to corticosteroids, but this case shows that it can also mimic infectious uveitis.
Combining tafasitamab with lenalidomide and rituximab significantly improves progression-free survival for patients with relapsed or refractory follicular lymphoma.
Primary liver cancers, mainly hepatocellular carcinomas (HCCs), are the third-leading cause of cancer-related deaths globally, posing a significant threat to public health [ 1 , 2 ]. HCC shows strong genomic, molecular, and histologic heterogeneity …
Liver masses are common in children, however primary malignant neoplasms are rare, representing only 1% of all pediatric cancers. Hepatocellular neoplasms are the most common primary liver malignancies and hepatoblastoma (HB) is the most …
Lung cancer is the most incident cancer in the world, accounting for 2,480,675 new cases in both sexes and at all stages, as well as the most lethal, with 1,817,469 deaths in both sexes at all ages in 2022 [ 1 ].
This meta-analysis aimed to assess the impact of genetic mutations, particularly in the NOTCH2 and TNFAIP3 genes, on the prognostic outcomes of Marginal Zone Lymphoma (MZL) patients. Databases, including PubMed, Embase, and Cochrane Library, were …
A series of patient cases underpin this interactive webinar that aims to provide practical guidance on a multidisciplinary approach to managing patients with cutaneous T-cell lymphoma.
An independent symposium at the 10th COMy World Congress focusing on BCMA-targeting strategies for the treatment of multiple myeloma. Gain insights into the latest clinical data and the implications for clinical practice.
The evolving landscape of metastatic urothelial carcinoma brings with it many challenges, such as optimally sequencing therapies and managing adverse events. Navigate your way through these with the Ultimate mUC challenge game and expert-to-expert interviews.
Supported by:
Merck Healthcare KGaA, Darmstadt, Germany and Astellas
Pelvic magnetic resonance imaging (MRI) is considered the standard of care for rectal cancer staging. Nevertheless, MRI regional metastatic lymph node assessment (N staging) is still associated with limited sensitivity and specificity [ 1 ].
Sarcopenia is characterized as a progressive loss of skeletal muscle mass and function, which leads to serious adverse effects on quality of life and survival [ 1 , 2 ]. The incidence of sarcopenia is associated with multiple factors such as cancer …
Low-grade endometrial stromal sarcoma (LG-ESS) can present diagnostic challenges, due to its overlapping morphological features with other uterine mesenchymal tumors. Misdiagnosis rates remain significant, and immunohistochemical data for LG-ESS …
Splenomegaly is a quite common clinical feature of Philadelphia (Ph) negative chronic myeloproliferative neoplasms (MPNs) and its presence may, in some cases, drives treatment decision. Most importantly, palpable splenomegaly is a minor criterion …
A man presenting with a skin rash and left leg weakness was diagnosed with sarcoid-like reaction due to treatment for chronic lymphocytic leukemia, and ultimately also amyotrophic lateral sclerosis when the motor symptoms progressed.
Diabetes and NET can adversely affect each other’s prognosis, but what impact do NET therapies have on diabetes and vice versa? And how should radiological and functional procedures be managed in patients with NET and diabetes?
